In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ... Read More The post Health Check: Telix jumps first hurdle with its ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...

Bayer has reported a major development within its pharmaceutical pipeline, with new clinical trial data indicating a significant improvement in survival rates for patients with advanced prostate ...

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...

News, features, and commentary about cancer-related issues ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Oncology Media Relations oncology_media_relations@its.jnj.com   Investor contact: Jessica Margevich investor-relations@its.jnj.com ...

(WISH) — The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The average age of men who get diagnosed is 67. Today, less than 1% ...

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

Celebrities have sent prostate cancer’s public profile soaring in recent years. But with accusations that some men are being harmed by over-testing, while those at highest risk are missing out on life ...

Salvage focal therapy and radical prostatectomy are both effective in treating localized radiorecurrent prostate cancer, a cohort study suggested. There were no statistically significant differences ...